BiotechTube

BAY85-8501 + Placebo

Phase 2Completed
0 watching 0 views this week⚡ Active
49
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Bronchiectasis

Conditions

Bronchiectasis

Trial Timeline

Apr 1, 2013 → Jun 1, 2014

NCT ID
NCT01818544

About BAY85-8501 + Placebo

BAY85-8501 + Placebo is a phase 2 stage product being developed by Bayer for Bronchiectasis. The current trial status is completed. This product is registered under clinical trial identifier NCT01818544. Target conditions include Bronchiectasis.

Hype Score Breakdown

Clinical
17
Activity
12
Company
7
Novelty
5
Community
5

Clinical Trials (1)

NCT IDPhaseStatus
NCT01818544Phase 2Completed

Competing Products

20 competing products in Bronchiectasis

See all competitors
ProductCompanyStageHype Score
Benralizumab + Placebo to BenralizumabAstraZenecaPhase 3
77
AZD9668 + PlaceboAstraZenecaPhase 2
52
AZD5069 + PlaceboAstraZenecaPhase 2
52
AZD0292AstraZenecaPhase 2
52
TIP + TIP and placebo + PlaceboNovartisPhase 2
52
Ciprofloxacin DPI (BAYQ3939) + PlaceboNovartisPhase 3
77
Placebo to Ciprofloxacin DPI (BAYQ3939)NovartisPre-clinical
23
Ciprofloxacin (BAYQ3939) dry powder for inhalation + Ciprofloxacin (BAYQ3939) dry powder for inhalation + Placebo + PlaceboNovartisPhase 3
77
QBW251 + PlaceboNovartisPhase 2
52
Ciprofloxacin (Cipro, BAYQ3939) + PlaceboNovartisPhase 2
52
AZLI + PlaceboGilead SciencesPhase 3
76
Aztreonam lysineGilead SciencesApproved
84
AZLIGilead SciencesPhase 2
51
AZLI + PlaceboGilead SciencesPhase 3
76
Itepekimab (SAR440340) + PlaceboSanofiPhase 2
51
CSL787 + PlaceboCSLPhase 1
32
CSL787 + PlaceboCSLPhase 2
51
HSK31858, tablet + PlaceboHaisco Pharmaceutical GroupPhase 3
74
HSK31858 + placeboHaisco Pharmaceutical GroupPhase 2
49
Group A + Group BBayerPre-clinical
20

Other Products from Bayer

TelmisartanApproved
82
Clotrimazole vaginal tablet + FluconazoleApproved
82
Levitra (Vardenafil, BAY38-9456)Approved
82
Avelox (Moxifloxacin, BAY12-8039) + Amoxicillin clavulanic acidApproved
82
Rivaroxaban 20 MG + WarfarinApproved
82